Impact of specific serotonin receptor modulation on behavioral flexibility.


Journal

Pharmacology, biochemistry, and behavior
ISSN: 1873-5177
Titre abrégé: Pharmacol Biochem Behav
Pays: United States
ID NLM: 0367050

Informations de publication

Date de publication:
10 2021
Historique:
received: 29 09 2020
revised: 06 07 2021
accepted: 09 07 2021
pubmed: 28 7 2021
medline: 23 2 2022
entrez: 27 7 2021
Statut: ppublish

Résumé

Serotonin (5-HT) is known to play a critical role in regulation of essential neural processes, whereas more recent research highlights serotonin's modulatory effects on cognition and executive functioning. Current examinations have identified specific serotonin receptors for their direct impact on behavioral flexibility. Providing definitive evidence for the impact of specific receptor targets on behavioral flexibility is difficult, due to the range of behavioral tests used. Due to limited studies and the sheer amount of different serotonin receptor targets, beginning to bring these studies together is important for the field. Our current review of the literature aims to differentiate how modulation of specific 5-HT receptors affects behavioral flexibility. Although more studies have examined 5-HT

Identifiants

pubmed: 34314738
pii: S0091-3057(21)00142-8
doi: 10.1016/j.pbb.2021.173243
pmc: PMC8429145
mid: NIHMS1732827
pii:
doi:

Substances chimiques

Receptor, Serotonin, 5-HT2A 0
Receptor, Serotonin, 5-HT2C 0
Receptors, Serotonin 0
Serotonin 333DO1RDJY

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

173243

Subventions

Organisme : NIGMS NIH HHS
ID : T34 GM136467
Pays : United States

Informations de copyright

Published by Elsevier Inc.

Références

Neuroscience. 2003;116(1):107-17
pubmed: 12535944
Int J Neuropsychopharmacol. 2012 Oct;15(9):1295-305
pubmed: 22008191
J Clin Invest. 2013 Dec;123(12):4986-91
pubmed: 24292660
Elife. 2017 Mar 21;6:
pubmed: 28322190
Mol Pharmacol. 2003 Dec;64(6):1295-308
pubmed: 14645659
Prog Brain Res. 2008;172:361-83
pubmed: 18772042
Pharmacol Ther. 2015 Jun;150:129-42
pubmed: 25601315
Psychol Neurosci. 2020 Sep;13(3):438-458
pubmed: 33613854
Psychopharmacology (Berl). 2011 Feb;213(2-3):243-64
pubmed: 21088958
Eur Neuropsychopharmacol. 2010 Sep;20(9):641-54
pubmed: 20488670
Behav Brain Res. 2013 Mar 1;240:171-81
pubmed: 23201361
Trends Neurosci. 2021 Jun;44(6):464-477
pubmed: 33674134
J Chem Neuroanat. 2005 Mar;29(2):83-91
pubmed: 15652696
Neuropsychopharmacology. 2014 Apr;39(5):1125-34
pubmed: 24196946
Psychopharmacology (Berl). 2017 May;234(9-10):1557-1571
pubmed: 28251298
Neuropsychopharmacology. 2018 Dec;43(13):2645-2651
pubmed: 30305705
Neuroscience. 2015 Jul 23;299:97-106
pubmed: 25934037
Behav Brain Res. 2018 Sep 3;349:8-15
pubmed: 29715539
Behav Brain Res. 2011 May 16;219(1):123-31
pubmed: 21232556
Neurosci Lett. 2003 Feb 20;338(1):1-4
pubmed: 12565126
Neuromolecular Med. 2004;5(1):27-40
pubmed: 15001810
Autism Res. 2014 Oct;7(5):555-67
pubmed: 24894823
Psychopharmacology (Berl). 2015 Nov;232(21-22):4017-31
pubmed: 26007324
Int J Neuropsychopharmacol. 2014 Oct;17(10):1695-706
pubmed: 24852131
J Neurosci. 2003 Sep 24;23(25):8771-80
pubmed: 14507977
Brain Res Bull. 2000 Apr;51(6):499-505
pubmed: 10758340
Neurosci Biobehav Rev. 2015 Sep;56:1-14
pubmed: 26112128
Neuroscience. 2017 Mar 14;345:12-26
pubmed: 26979052
Psychol Med. 2020 Oct;50(13):2255-2264
pubmed: 31500679
Genes Brain Behav. 2017 Mar;16(3):342-351
pubmed: 27717169
Behav Brain Res. 2013 Jul 1;248:136-40
pubmed: 23603557
Neuropsychopharmacology. 2015 Jun;40(7):1619-30
pubmed: 25567428
Psychopharmacology (Berl). 2016 Feb;233(4):649-60
pubmed: 26558619
Genes Brain Behav. 2015 Jan;14(1):4-21
pubmed: 25561028
Neuropharmacology. 1997 Apr-May;36(4-5):609-20
pubmed: 9225286
Chem Rev. 2008 May;108(5):1614-41
pubmed: 18476671
Neurosci Lett. 2020 Nov 1;738:135378
pubmed: 32920046
Psychopharmacology (Berl). 2018 Jul;235(7):2101-2111
pubmed: 29682701
Neuropharmacology. 2016 Jun;105:351-360
pubmed: 26826431
Eur J Neurosci. 2011 Jul;34(2):343-51
pubmed: 21714816
Front Behav Neurosci. 2019 Jun 28;13:127
pubmed: 31316358
Pharmacol Ther. 2006 Sep;111(3):707-14
pubmed: 16516972
Pharmacol Ther. 2007 Feb;113(2):296-320
pubmed: 17049611
Behav Brain Res. 2008 Dec 16;195(1):198-213
pubmed: 18571247
Biochem Biophys Res Commun. 1993 May 28;193(1):268-76
pubmed: 8389146
Behav Brain Res. 2018 Sep 3;349:16-24
pubmed: 29715538
Science. 2011 Jul 29;333(6042):637-42
pubmed: 21798952
Psychopharmacology (Berl). 2010 Jan;208(1):13-21
pubmed: 19902184
Behav Brain Res. 2020 Oct 1;395:112861
pubmed: 32814148
J Psychopharmacol. 2017 Sep;31(9):1091-1120
pubmed: 28858536
Trends Pharmacol Sci. 2004 Sep;25(9):481-6
pubmed: 15559250
Neuropsychopharmacology. 2008 Jul;33(8):2007-19
pubmed: 17957219
Behav Brain Res. 2015 Jan 15;277:68-77
pubmed: 25078294
Psychopharmacology (Berl). 2005 Sep;181(2):253-9
pubmed: 15846482
Annu Rev Med. 2009;60:355-66
pubmed: 19630576
Eur Neuropsychopharmacol. 2014 Jun;24(6):919-29
pubmed: 24613076
Psychopharmacology (Berl). 2009 Jan;202(1-3):329-41
pubmed: 18587666
Anim Cogn. 2020 Sep;23(5):901-911
pubmed: 32440792
J Neurosci. 2010 Jan 20;30(3):930-8
pubmed: 20089901
Psychopharmacology (Berl). 2012 Apr;220(4):687-96
pubmed: 21989804

Auteurs

Bryan D Alvarez (BD)

California State University San Bernardino, Department of Psychology, 5500 University Parkway, San Bernardino, CA 92407, United States of America.

Cheyenne A Morales (CA)

California State University San Bernardino, Department of Psychology, 5500 University Parkway, San Bernardino, CA 92407, United States of America.

Dionisio A Amodeo (DA)

California State University San Bernardino, Department of Psychology, 5500 University Parkway, San Bernardino, CA 92407, United States of America. Electronic address: dionisio.amodeo@csusb.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH